 | • レポートコード：MRC2312MG12579 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の抗菌剤耐性サーベイランス市場規模と予測を収録しています。・世界の抗菌剤耐性サーベイランス市場：売上、2018年-2023年、2024年-2029年 ・世界の抗菌剤耐性サーベイランス市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の抗菌剤耐性サーベイランス市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「診断キット」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 抗菌剤耐性サーベイランスのグローバル主要企業は、BD、 Biomerieux、 Thermo Fisher Scientific、 Danaher、 Luminex、 Bruker、 Merck KgaA、 Bio-Rad、 Qiagen、 Abbott Laboratories、 Roche Diagnostics、 OpGen、 Wolters Kluwer、 Lumed、 BioSpace、 Cepheid、 Accelerate Diagnostics、 Liofilchem、 Alifax S.r.l.、 Bioanalyseなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、抗菌剤耐性サーベイランスのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の抗菌剤耐性サーベイランス市場：タイプ別、2018年-2023年、2024年-2029年 世界の抗菌剤耐性サーベイランス市場：タイプ別市場シェア、2022年 ・診断キット、診断システム、監視ソフトウェア 世界の抗菌剤耐性サーベイランス市場：用途別、2018年-2023年、2024年-2029年 世界の抗菌剤耐性サーベイランス市場：用途別市場シェア、2022年 ・病院、研究所、その他 世界の抗菌剤耐性サーベイランス市場：地域・国別、2018年-2023年、2024年-2029年 世界の抗菌剤耐性サーベイランス市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における抗菌剤耐性サーベイランスのグローバル売上、2018年-2023年 ・主要企業における抗菌剤耐性サーベイランスのグローバル売上シェア、2022年 ・主要企業における抗菌剤耐性サーベイランスのグローバル販売量、2018年-2023年 ・主要企業における抗菌剤耐性サーベイランスのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 BD、 Biomerieux、 Thermo Fisher Scientific、 Danaher、 Luminex、 Bruker、 Merck KgaA、 Bio-Rad、 Qiagen、 Abbott Laboratories、 Roche Diagnostics、 OpGen、 Wolters Kluwer、 Lumed、 BioSpace、 Cepheid、 Accelerate Diagnostics、 Liofilchem、 Alifax S.r.l.、 Bioanalyse ************************************************************* ・調査・分析レポートの概要 抗菌剤耐性サーベイランス市場の定義 市場セグメント 世界の抗菌剤耐性サーベイランス市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の抗菌剤耐性サーベイランス市場規模 世界の抗菌剤耐性サーベイランス市場規模：2022年 VS 2029年 世界の抗菌剤耐性サーベイランス市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの抗菌剤耐性サーベイランスの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の抗菌剤耐性サーベイランス製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：診断キット、診断システム、監視ソフトウェア 抗菌剤耐性サーベイランスのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、研究所、その他 抗菌剤耐性サーベイランスの用途別グローバル売上・予測 ・地域別市場分析 地域別抗菌剤耐性サーベイランス市場規模 2022年と2029年 地域別抗菌剤耐性サーベイランス売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） BD、 Biomerieux、 Thermo Fisher Scientific、 Danaher、 Luminex、 Bruker、 Merck KgaA、 Bio-Rad、 Qiagen、 Abbott Laboratories、 Roche Diagnostics、 OpGen、 Wolters Kluwer、 Lumed、 BioSpace、 Cepheid、 Accelerate Diagnostics、 Liofilchem、 Alifax S.r.l.、 Bioanalyse ... |
This research report provides a comprehensive analysis of the Antimicrobial Resistance Surveillance market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Antimicrobial Resistance Surveillance market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Antimicrobial Resistance Surveillance, challenges faced by the industry, and potential opportunities for market players.
The global Antimicrobial Resistance Surveillance market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Antimicrobial Resistance Surveillance market presents opportunities for various stakeholders, including Hospitals, Research institute. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Antimicrobial Resistance Surveillance market. Additionally, the growing consumer demand present avenues for market expansion.
The global Antimicrobial Resistance Surveillance market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Antimicrobial Resistance Surveillance market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Antimicrobial Resistance Surveillance market.
Market Overview: The report provides a comprehensive overview of the Antimicrobial Resistance Surveillance market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Diagnostic Kit, Diagnostic System), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Antimicrobial Resistance Surveillance market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Antimicrobial Resistance Surveillance market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Antimicrobial Resistance Surveillance market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Antimicrobial Resistance Surveillance market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Antimicrobial Resistance Surveillance market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Antimicrobial Resistance Surveillance market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Antimicrobial Resistance Surveillance, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Antimicrobial Resistance Surveillance market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Antimicrobial Resistance Surveillance market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Diagnostic Kit
Diagnostic System
Surveillance Software
Market segment by Application
Hospitals
Research institute
Others
Global Antimicrobial Resistance Surveillance Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
BD
Biomerieux
Thermo Fisher Scientific
Danaher
Luminex
Bruker
Merck KgaA
Bio-Rad
Qiagen
Abbott Laboratories
Roche Diagnostics
OpGen
Wolters Kluwer
Lumed
BioSpace
Cepheid
Accelerate Diagnostics
Liofilchem
Alifax S.r.l.
Bioanalyse
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antimicrobial Resistance Surveillance, market overview.
Chapter 2: Global Antimicrobial Resistance Surveillance market size in revenue and volume.
Chapter 3: Detailed analysis of Antimicrobial Resistance Surveillance manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antimicrobial Resistance Surveillance in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Antimicrobial Resistance Surveillance capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Antimicrobial Resistance Surveillance Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antimicrobial Resistance Surveillance Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antimicrobial Resistance Surveillance Overall Market Size
2.1 Global Antimicrobial Resistance Surveillance Market Size: 2022 VS 2029
2.2 Global Antimicrobial Resistance Surveillance Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Antimicrobial Resistance Surveillance Sales: 2018-2029
3 Company Landscape
3.1 Top Antimicrobial Resistance Surveillance Players in Global Market
3.2 Top Global Antimicrobial Resistance Surveillance Companies Ranked by Revenue
3.3 Global Antimicrobial Resistance Surveillance Revenue by Companies
3.4 Global Antimicrobial Resistance Surveillance Sales by Companies
3.5 Global Antimicrobial Resistance Surveillance Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Antimicrobial Resistance Surveillance Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Antimicrobial Resistance Surveillance Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antimicrobial Resistance Surveillance Players in Global Market
3.8.1 List of Global Tier 1 Antimicrobial Resistance Surveillance Companies
3.8.2 List of Global Tier 2 and Tier 3 Antimicrobial Resistance Surveillance Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Antimicrobial Resistance Surveillance Market Size Markets, 2022 & 2029
4.1.2 Diagnostic Kit
4.1.3 Diagnostic System
4.1.4 Surveillance Software
4.2 By Type – Global Antimicrobial Resistance Surveillance Revenue & Forecasts
4.2.1 By Type – Global Antimicrobial Resistance Surveillance Revenue, 2018-2023
4.2.2 By Type – Global Antimicrobial Resistance Surveillance Revenue, 2024-2029
4.2.3 By Type – Global Antimicrobial Resistance Surveillance Revenue Market Share, 2018-2029
4.3 By Type – Global Antimicrobial Resistance Surveillance Sales & Forecasts
4.3.1 By Type – Global Antimicrobial Resistance Surveillance Sales, 2018-2023
4.3.2 By Type – Global Antimicrobial Resistance Surveillance Sales, 2024-2029
4.3.3 By Type – Global Antimicrobial Resistance Surveillance Sales Market Share, 2018-2029
4.4 By Type – Global Antimicrobial Resistance Surveillance Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Antimicrobial Resistance Surveillance Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Research institute
5.1.4 Others
5.2 By Application – Global Antimicrobial Resistance Surveillance Revenue & Forecasts
5.2.1 By Application – Global Antimicrobial Resistance Surveillance Revenue, 2018-2023
5.2.2 By Application – Global Antimicrobial Resistance Surveillance Revenue, 2024-2029
5.2.3 By Application – Global Antimicrobial Resistance Surveillance Revenue Market Share, 2018-2029
5.3 By Application – Global Antimicrobial Resistance Surveillance Sales & Forecasts
5.3.1 By Application – Global Antimicrobial Resistance Surveillance Sales, 2018-2023
5.3.2 By Application – Global Antimicrobial Resistance Surveillance Sales, 2024-2029
5.3.3 By Application – Global Antimicrobial Resistance Surveillance Sales Market Share, 2018-2029
5.4 By Application – Global Antimicrobial Resistance Surveillance Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Antimicrobial Resistance Surveillance Market Size, 2022 & 2029
6.2 By Region – Global Antimicrobial Resistance Surveillance Revenue & Forecasts
6.2.1 By Region – Global Antimicrobial Resistance Surveillance Revenue, 2018-2023
6.2.2 By Region – Global Antimicrobial Resistance Surveillance Revenue, 2024-2029
6.2.3 By Region – Global Antimicrobial Resistance Surveillance Revenue Market Share, 2018-2029
6.3 By Region – Global Antimicrobial Resistance Surveillance Sales & Forecasts
6.3.1 By Region – Global Antimicrobial Resistance Surveillance Sales, 2018-2023
6.3.2 By Region – Global Antimicrobial Resistance Surveillance Sales, 2024-2029
6.3.3 By Region – Global Antimicrobial Resistance Surveillance Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Antimicrobial Resistance Surveillance Revenue, 2018-2029
6.4.2 By Country – North America Antimicrobial Resistance Surveillance Sales, 2018-2029
6.4.3 US Antimicrobial Resistance Surveillance Market Size, 2018-2029
6.4.4 Canada Antimicrobial Resistance Surveillance Market Size, 2018-2029
6.4.5 Mexico Antimicrobial Resistance Surveillance Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Antimicrobial Resistance Surveillance Revenue, 2018-2029
6.5.2 By Country – Europe Antimicrobial Resistance Surveillance Sales, 2018-2029
6.5.3 Germany Antimicrobial Resistance Surveillance Market Size, 2018-2029
6.5.4 France Antimicrobial Resistance Surveillance Market Size, 2018-2029
6.5.5 U.K. Antimicrobial Resistance Surveillance Market Size, 2018-2029
6.5.6 Italy Antimicrobial Resistance Surveillance Market Size, 2018-2029
6.5.7 Russia Antimicrobial Resistance Surveillance Market Size, 2018-2029
6.5.8 Nordic Countries Antimicrobial Resistance Surveillance Market Size, 2018-2029
6.5.9 Benelux Antimicrobial Resistance Surveillance Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Antimicrobial Resistance Surveillance Revenue, 2018-2029
6.6.2 By Region – Asia Antimicrobial Resistance Surveillance Sales, 2018-2029
6.6.3 China Antimicrobial Resistance Surveillance Market Size, 2018-2029
6.6.4 Japan Antimicrobial Resistance Surveillance Market Size, 2018-2029
6.6.5 South Korea Antimicrobial Resistance Surveillance Market Size, 2018-2029
6.6.6 Southeast Asia Antimicrobial Resistance Surveillance Market Size, 2018-2029
6.6.7 India Antimicrobial Resistance Surveillance Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Antimicrobial Resistance Surveillance Revenue, 2018-2029
6.7.2 By Country – South America Antimicrobial Resistance Surveillance Sales, 2018-2029
6.7.3 Brazil Antimicrobial Resistance Surveillance Market Size, 2018-2029
6.7.4 Argentina Antimicrobial Resistance Surveillance Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Antimicrobial Resistance Surveillance Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Antimicrobial Resistance Surveillance Sales, 2018-2029
6.8.3 Turkey Antimicrobial Resistance Surveillance Market Size, 2018-2029
6.8.4 Israel Antimicrobial Resistance Surveillance Market Size, 2018-2029
6.8.5 Saudi Arabia Antimicrobial Resistance Surveillance Market Size, 2018-2029
6.8.6 UAE Antimicrobial Resistance Surveillance Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 BD
7.1.1 BD Company Summary
7.1.2 BD Business Overview
7.1.3 BD Antimicrobial Resistance Surveillance Major Product Offerings
7.1.4 BD Antimicrobial Resistance Surveillance Sales and Revenue in Global (2018-2023)
7.1.5 BD Key News & Latest Developments
7.2 Biomerieux
7.2.1 Biomerieux Company Summary
7.2.2 Biomerieux Business Overview
7.2.3 Biomerieux Antimicrobial Resistance Surveillance Major Product Offerings
7.2.4 Biomerieux Antimicrobial Resistance Surveillance Sales and Revenue in Global (2018-2023)
7.2.5 Biomerieux Key News & Latest Developments
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Company Summary
7.3.2 Thermo Fisher Scientific Business Overview
7.3.3 Thermo Fisher Scientific Antimicrobial Resistance Surveillance Major Product Offerings
7.3.4 Thermo Fisher Scientific Antimicrobial Resistance Surveillance Sales and Revenue in Global (2018-2023)
7.3.5 Thermo Fisher Scientific Key News & Latest Developments
7.4 Danaher
7.4.1 Danaher Company Summary
7.4.2 Danaher Business Overview
7.4.3 Danaher Antimicrobial Resistance Surveillance Major Product Offerings
7.4.4 Danaher Antimicrobial Resistance Surveillance Sales and Revenue in Global (2018-2023)
7.4.5 Danaher Key News & Latest Developments
7.5 Luminex
7.5.1 Luminex Company Summary
7.5.2 Luminex Business Overview
7.5.3 Luminex Antimicrobial Resistance Surveillance Major Product Offerings
7.5.4 Luminex Antimicrobial Resistance Surveillance Sales and Revenue in Global (2018-2023)
7.5.5 Luminex Key News & Latest Developments
7.6 Bruker
7.6.1 Bruker Company Summary
7.6.2 Bruker Business Overview
7.6.3 Bruker Antimicrobial Resistance Surveillance Major Product Offerings
7.6.4 Bruker Antimicrobial Resistance Surveillance Sales and Revenue in Global (2018-2023)
7.6.5 Bruker Key News & Latest Developments
7.7 Merck KgaA
7.7.1 Merck KgaA Company Summary
7.7.2 Merck KgaA Business Overview
7.7.3 Merck KgaA Antimicrobial Resistance Surveillance Major Product Offerings
7.7.4 Merck KgaA Antimicrobial Resistance Surveillance Sales and Revenue in Global (2018-2023)
7.7.5 Merck KgaA Key News & Latest Developments
7.8 Bio-Rad
7.8.1 Bio-Rad Company Summary
7.8.2 Bio-Rad Business Overview
7.8.3 Bio-Rad Antimicrobial Resistance Surveillance Major Product Offerings
7.8.4 Bio-Rad Antimicrobial Resistance Surveillance Sales and Revenue in Global (2018-2023)
7.8.5 Bio-Rad Key News & Latest Developments
7.9 Qiagen
7.9.1 Qiagen Company Summary
7.9.2 Qiagen Business Overview
7.9.3 Qiagen Antimicrobial Resistance Surveillance Major Product Offerings
7.9.4 Qiagen Antimicrobial Resistance Surveillance Sales and Revenue in Global (2018-2023)
7.9.5 Qiagen Key News & Latest Developments
7.10 Abbott Laboratories
7.10.1 Abbott Laboratories Company Summary
7.10.2 Abbott Laboratories Business Overview
7.10.3 Abbott Laboratories Antimicrobial Resistance Surveillance Major Product Offerings
7.10.4 Abbott Laboratories Antimicrobial Resistance Surveillance Sales and Revenue in Global (2018-2023)
7.10.5 Abbott Laboratories Key News & Latest Developments
7.11 Roche Diagnostics
7.11.1 Roche Diagnostics Company Summary
7.11.2 Roche Diagnostics Business Overview
7.11.3 Roche Diagnostics Antimicrobial Resistance Surveillance Major Product Offerings
7.11.4 Roche Diagnostics Antimicrobial Resistance Surveillance Sales and Revenue in Global (2018-2023)
7.11.5 Roche Diagnostics Key News & Latest Developments
7.12 OpGen
7.12.1 OpGen Company Summary
7.12.2 OpGen Business Overview
7.12.3 OpGen Antimicrobial Resistance Surveillance Major Product Offerings
7.12.4 OpGen Antimicrobial Resistance Surveillance Sales and Revenue in Global (2018-2023)
7.12.5 OpGen Key News & Latest Developments
7.13 Wolters Kluwer
7.13.1 Wolters Kluwer Company Summary
7.13.2 Wolters Kluwer Business Overview
7.13.3 Wolters Kluwer Antimicrobial Resistance Surveillance Major Product Offerings
7.13.4 Wolters Kluwer Antimicrobial Resistance Surveillance Sales and Revenue in Global (2018-2023)
7.13.5 Wolters Kluwer Key News & Latest Developments
7.14 Lumed
7.14.1 Lumed Company Summary
7.14.2 Lumed Business Overview
7.14.3 Lumed Antimicrobial Resistance Surveillance Major Product Offerings
7.14.4 Lumed Antimicrobial Resistance Surveillance Sales and Revenue in Global (2018-2023)
7.14.5 Lumed Key News & Latest Developments
7.15 BioSpace
7.15.1 BioSpace Company Summary
7.15.2 BioSpace Business Overview
7.15.3 BioSpace Antimicrobial Resistance Surveillance Major Product Offerings
7.15.4 BioSpace Antimicrobial Resistance Surveillance Sales and Revenue in Global (2018-2023)
7.15.5 BioSpace Key News & Latest Developments
7.16 Cepheid
7.16.1 Cepheid Company Summary
7.16.2 Cepheid Business Overview
7.16.3 Cepheid Antimicrobial Resistance Surveillance Major Product Offerings
7.16.4 Cepheid Antimicrobial Resistance Surveillance Sales and Revenue in Global (2018-2023)
7.16.5 Cepheid Key News & Latest Developments
7.17 Accelerate Diagnostics
7.17.1 Accelerate Diagnostics Company Summary
7.17.2 Accelerate Diagnostics Business Overview
7.17.3 Accelerate Diagnostics Antimicrobial Resistance Surveillance Major Product Offerings
7.17.4 Accelerate Diagnostics Antimicrobial Resistance Surveillance Sales and Revenue in Global (2018-2023)
7.17.5 Accelerate Diagnostics Key News & Latest Developments
7.18 Liofilchem
7.18.1 Liofilchem Company Summary
7.18.2 Liofilchem Business Overview
7.18.3 Liofilchem Antimicrobial Resistance Surveillance Major Product Offerings
7.18.4 Liofilchem Antimicrobial Resistance Surveillance Sales and Revenue in Global (2018-2023)
7.18.5 Liofilchem Key News & Latest Developments
7.19 Alifax S.r.l.
7.19.1 Alifax S.r.l. Company Summary
7.19.2 Alifax S.r.l. Business Overview
7.19.3 Alifax S.r.l. Antimicrobial Resistance Surveillance Major Product Offerings
7.19.4 Alifax S.r.l. Antimicrobial Resistance Surveillance Sales and Revenue in Global (2018-2023)
7.19.5 Alifax S.r.l. Key News & Latest Developments
7.20 Bioanalyse
7.20.1 Bioanalyse Company Summary
7.20.2 Bioanalyse Business Overview
7.20.3 Bioanalyse Antimicrobial Resistance Surveillance Major Product Offerings
7.20.4 Bioanalyse Antimicrobial Resistance Surveillance Sales and Revenue in Global (2018-2023)
7.20.5 Bioanalyse Key News & Latest Developments
8 Global Antimicrobial Resistance Surveillance Production Capacity, Analysis
8.1 Global Antimicrobial Resistance Surveillance Production Capacity, 2018-2029
8.2 Antimicrobial Resistance Surveillance Production Capacity of Key Manufacturers in Global Market
8.3 Global Antimicrobial Resistance Surveillance Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Antimicrobial Resistance Surveillance Supply Chain Analysis
10.1 Antimicrobial Resistance Surveillance Industry Value Chain
10.2 Antimicrobial Resistance Surveillance Upstream Market
10.3 Antimicrobial Resistance Surveillance Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Antimicrobial Resistance Surveillance Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer